Abbott Laboratories vs. Regeneron Pharmaceuticals Inc
Abbott Laboratories (ABT) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| ABT | REGN | |
|---|---|---|
| Market Cap | $189.28 billion | $94.76 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | REGN | |
|---|---|---|
| Dividend Yield | 2.31% | 0.39% |
ABT leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | REGN | |
|---|---|---|
| Short Interest | 0.57% | 1.82% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, REGN overview, REGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.